Raymond James Financial
TAK icon

Raymond James Financial’s Takeda Pharmaceutical TAK Stock Holding History

Raymond James Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.55M Buy
408,739
+96,723
+31% +$1.6M ﹤0.01% 2527
2026
Q1 		$5.77M Buy
312,016
+138,407
+80% +$2.43M ﹤0.01% 2476
2025
Q4 		$2.71M Buy
173,609
+19,451
+13% +$278K ﹤0.01% 3031
2025
Q3 		$2.26M Buy
154,158
+10,465
+7% +$155K ﹤0.01% 3087
2025
Q2 		$2.22M Buy
143,693
+61,511
+75% +$909K ﹤0.01% 2997
2025
Q1 		$1.22M Sell
82,182
-27,135
-25% -$380K ﹤0.01% 3342
2024
Q4 		$1.45M Buy
+109,317
New +$1.5M ﹤0.01% 3198

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Raymond James Financial's TAK Position: Q2 2026 in Review

Raymond James Financial increased its Takeda Pharmaceutical (TAK) stake by 31% in Q2 2026, buying an estimated $1.6M and bringing the position to 408,739 shares worth $6.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Raymond James Financial first reported a position in TAK in Q4 2024 and has held it in 7 quarters since. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Raymond James Financial held 408,739 shares of Takeda Pharmaceutical worth $6.55M as of Q2 2026.
  • Raymond James Financial bought 96,723 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.6M.
  • Takeda Pharmaceutical made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2527 holding.
  • Raymond James Financial first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.